Eli Lilly and Co (LLY):企業の財務・戦略的SWOT分析

◆英語タイトル:Eli Lilly and Co (LLY) - Financial and Strategic SWOT Analysis Review
◆商品コード:SWOT20MY1658
◆発行会社(調査会社):GlobalData
◆発行日:2020年4月
◆ページ数:77
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥14,375見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥28,750見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥43,125見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Eli Lilly and Co (LLY) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Eli Lilly and Co (Lilly) is a healthcare company that discovers, develops and markets human healthcare products. The company offers medicines for cardiovascular conditions, diabetes, endocrinology, cancer, neurological problems, immune disorders, men’s health and musculoskeletal problems. The company distributes its pharmaceutical health products through independent wholesale distributors. It also promotes products through sales representatives and marketing agreements with other pharmaceutical companies. The company offers its products in North America, South America, Europe, South Asia, the Middle East, Africa and North Asia-Pacific. Lilly is headquartered in Indianapolis, Indiana, the US.

Eli Lilly and Co Key Recent Developments

Apr 23,2020 Lilly reports strong first-quarter financial results, Adjusts EPS Guidance
Apr 07,2020 New $35 co-pay now available through Lilly insulin value program in response to COVID-19 crisis in U.S.
Apr 01,2020 Sitryx signs potential $880m drug development deal
Apr 01,2020 Medical professionals across Merck & Co., Pfizer and Eli Lilly and Company activate to support health systems, first responders and patients amid COVID-19 pandemic

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Eli Lilly and Co – Key Facts
Eli Lilly and Co – Key Employees
Eli Lilly and Co – Key Employee Biographies
Eli Lilly and Co – Major Products and Services
Eli Lilly and Co – History
Eli Lilly and Co – Company Statement
Eli Lilly and Co – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Joint Venture
Section 2 – Company Analysis
Company Overview
Eli Lilly and Co – Business Description
Business Segment: Human Pharmaceuticals
Overview
Performance
Geographical Segment: Europe
Performance
Geographical Segment: Japan
Performance
Geographical Segment: Other Foreign Countries
Performance
Geographical Segment: United States
Performance
R&D Overview
Eli Lilly and Co – Corporate Strategy
Eli Lilly and Co – SWOT Analysis
SWOT Analysis – Overview
Eli Lilly and Co – Strengths
Eli Lilly and Co – Weaknesses
Eli Lilly and Co – Opportunities
Eli Lilly and Co – Threats
Eli Lilly and Co – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Eli Lilly and Co, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Eli Lilly and Co, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Eli Lilly and Co, Recent Deals Summary
Section 5 – Company’s Recent Developments
Apr 23, 2020: Lilly reports strong first-quarter financial results, Adjusts EPS Guidance
Apr 07, 2020: New $35 co-pay now available through Lilly insulin value program in response to COVID-19 crisis in U.S.
Apr 01, 2020: Sitryx signs potential $880m drug development deal
Apr 01, 2020: Medical professionals across Merck & Co., Pfizer and Eli Lilly and Company activate to support health systems, first responders and patients amid COVID-19 pandemic
Mar 27, 2020: Novartis partners with life sciences companies to fight Covid-19
Mar 26, 2020: Novartis and life sciences companies commit expertise and assets to the fight against COVID-19 pandemic alongside Bill & Melinda Gates Foundation
Mar 24, 2020: Updates from Lilly about insulin supply and affordability
Mar 23, 2020: Eli Lilly to delay clinical trial activities amid Covid-19 pandemic
Mar 22, 2020: Lilly to provide drive-through COVID-19 testing for Indianapolis Health Care Workers
Mar 20, 2020: Eli Lilly Partners with State of Indiana to Accelerate COVID-19 Testing
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Eli Lilly and Co, Key Facts
Eli Lilly and Co, Key Employees
Eli Lilly and Co, Key Employee Biographies
Eli Lilly and Co, Major Products and Services
Eli Lilly and Co, History
Eli Lilly and Co, Subsidiaries
Eli Lilly and Co, Joint Venture
Eli Lilly and Co, Key Competitors
Eli Lilly and Co, Ratios based on current share price
Eli Lilly and Co, Annual Ratios
Eli Lilly and Co, Annual Ratios (Cont...1)
Eli Lilly and Co, Annual Ratios (Cont...2)
Eli Lilly and Co, Interim Ratios
Eli Lilly and Co, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Eli Lilly and Co, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Eli Lilly and Co, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Eli Lilly and Co, Performance Chart (2015 - 2019)
Eli Lilly and Co, Ratio Charts
Eli Lilly and Co, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Eli Lilly and Co, Pharmaceuticals & Healthcare, Deals by Type, 2014 to YTD 2020

★海外企業調査レポート[Eli Lilly and Co (LLY):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Saje Pharma LLC-製薬・医療分野:企業M&A・提携分析
    Summary Saje Pharma LLC (Saje Pharma) is a biopharmaceutical company that develops new therapeutic agents for rare and common diseases with unmet medical needs. The company’s lead product candidate includes SPL-334, developed for various indications such as idiopathic pulmonary fibrosis, asthma, inf …
  • HTC Corporation:企業のM&A・事業提携・投資動向
    HTC Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's HTC Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestm …
  • SFJ Pharmaceuticals Inc-製薬・医療分野:企業M&A・提携分析
    Summary SFJ Pharmaceuticals Inc (SFJ Pharmaceuticals) is a drug company that provides funding and strategic development expertise services. The company offers management of phase III oncology clinical trials, phase II trials and regulatory approvals. Its services includes clinical operations, busine …
  • Autobahn Tank & Rast Holding GmbH:企業の戦略・SWOT・財務情報
    Autobahn Tank & Rast Holding GmbH - Strategy, SWOT and Corporate Finance Report Summary Autobahn Tank & Rast Holding GmbH - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • NG Biotech:企業の製品パイプライン分析
    Summary NG Biotech (NG Biotech) is a biotech company that develops and manufactures novel in vitro diagnostic tools for therapy monitoring. The company’s products include whole blood pregnancy tests, M-health malaria tests, NG Test readers, antibiotic resistance tests, and OTC tests. It also develop …
  • Quidel Corp (QDEL)-医療機器分野:企業M&A・提携分析
    Summary Quidel Corp (Quidel) develops, manufactures and markets rapid diagnostic testing solutions for the detection and diagnosis of critical diseases and other medical conditions. Its major products include immunoassays; molecular assays; virology products including traditional cell lines, specime …
  • CEDA International Corp:石油・ガス:M&Aディール及び事業提携情報
    Summary CEDA International Corp (CEDA) is an oil and gas company that offers energy services. The company provides services such as turnaround, industrial maintenance, electrical services, exchanger services, hydro-testing and pipe isolation services, and construction services, among others. It also …
  • Cantabio Pharmaceuticals Inc (CTBO):製薬・医療:M&Aディール及び事業提携情報
    Summary Cantabio Pharmaceuticals Inc (Cantabio Pharmaceuticals) is a biotechnology company that concentrates on the commercializing of novel therapies for Parkinson’s disease, Alzheimer’s disease and neurodegenerative diseases. The company provide pipeline product candidates such as CB101 and CB102, …
  • LegoChem Biosciences Inc (141080):企業の財務・戦略的SWOT分析
    Summary LegoChem Biosciences Inc (LCB) is a bio pharmaceutical company that develops next generation novel therapeutics. The company utilizes its proprietary medicinal drug discovery technology LegoChemistry and ADC platform technology ConjuAll. It manufactures drugs in the therapeutic areas of anti …
  • DCP Midstream LP (DCP):企業の財務・戦略的SWOT分析
    DCP Midstream LP (DCP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • APEIRON Biologics AG:製薬・医療:M&Aディール及び事業提携情報
    Summary APEIRON Biologics AG (APEIRON) is a clinical-stage biotechnology company that concentrates on the development of biological and immunological solutions for the treatment of various cancers. The company’s pipeline products include APN01, APN301, APN311, APN401, APN411, APN421 and APN431. Its …
  • AltaGas Ltd.:企業の戦略・SWOT・財務情報
    AltaGas Ltd. - Strategy, SWOT and Corporate Finance Report Summary AltaGas Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Pentair plc (PNR)-エネルギー分野:企業M&A・提携分析
    Summary Pentair plc (Pentair) is an industrial manufacturing company. It designs, manufactures and markets water system products and solutions for filtration, separation and fluid process management; and products that guard sensitive electrical and electronic equipment; and heat management solutions …
  • Herman Miller, Inc.:企業の戦略・SWOT・財務分析
    Herman Miller, Inc. - Strategy, SWOT and Corporate Finance Report Summary Herman Miller, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Business Development Bank Of Canada
    Business Development Bank Of Canada - Strategy, SWOT and Corporate Finance Report Summary Business Development Bank Of Canada - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • Brigham and Women’s Hospital:企業のM&A・事業提携・投資動向
    Brigham and Women's Hospital - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Brigham and Women's Hospital Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and a …
  • Endeavour Mining Corporation:企業の戦略・SWOT・財務情報
    Endeavour Mining Corporation - Strategy, SWOT and Corporate Finance Report Summary Endeavour Mining Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • 4imprint Group plc (FOUR):企業の財務・戦略的SWOT分析
    4imprint Group plc (FOUR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Agile Therapeutics Inc (AGRX):企業の財務・戦略的SWOT分析
    Summary Agile Therapeutics Inc (Agile) is a healthcare company that develops and commercializes prescription contraceptive products for women. The company provides contraceptive patch containing the active ingredients levonorgestrel and ethinyl estradiol and progestin-only birth control patch. Its p …
  • FANCL Corporation:企業の戦略・SWOT・財務情報
    FANCL Corporation - Strategy, SWOT and Corporate Finance Report Summary FANCL Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆